Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 145

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 145
---
 financial instruments(445)(694)(550)Gain on sale of business201 — — Total revenues177,011 171,340 156,595 ExpensesBenefit expense127,567 124,330 116,642 Cost of products sold19,750 17,293 13,035 Operating expense20,025 20,087 17,700 Interest expense1,185 1,030 851 Amortization of other intangible assets580 885 767 Total expenses169,107 163,625 148,995 Income before income tax expense 7,904 7,715 7,600 Income tax expense1,933 1,724 1,712 Net income5,971 5,991 5,888 Net loss (gain) attributable to noncontrolling interests9 (4)6 Shareholders’ net income$5,980 $5,987 $5,894 Shareholders’ earnings per shareBasic $25.81 $25.38 $24.56 Diluted $25.68 $25.22 $24.28 

See accompanying notes.

 -71-

Elevance Health, Inc.

Consolidated Statements of Comprehensive Income

 Years Ended December 31(In millions)202420232022Net income$5,971 $5,991 $5,888 Other comprehensive income (loss), net of tax:Change in net unrealized gains/losses on investments103 1,117 (2,260)Change in non-credit component of impairment losses on investments1 — (3)Change in net unrealized gains/losses on cash flow hedges4 18 10 Change in net periodic pension and other benefit costs60 40 (70)Change in future policy benefits(2)(3)32 Foreign currency translation adjustments(6)(1)(13)Other comprehensive income (loss)160 1,171 (2,304)Net loss (gain) attributable to noncontrolling interests9 (4)6 Other comprehensive loss attributable to noncontrolling interests6 6 11 Total shareholders’ comprehensive income$6,146 $7,164 $3,601 

See accompanying notes.

 -72-

Elevance Health, Inc.

Consolidated Statements of Cash Flows

 Years Ended December 31(In millions)202420232